HTA

All the posts published.

MORSE Consulting Bolsters Private Payer Expertise

September 9, 2020

-

Market Access News, What's New

-

Posted by MORSE

CADTH Pharmaceutical Reviews Update, Issue 16

July 10, 2020

-

Market Access News

-

Posted by MORSE

CADTH Business Plan 2020-2021 Insights

May 12, 2020

-

Market Access News

-

Posted by MORSE

Summary of CADTH Pharmaceutical Reviews Update – Issue 15

May 6, 2020

-

Market Access News

-

Posted by MORSE

April 2020 Update to The Canadian Reimbursement Trends & Timelines Report – Now Available

April 27, 2020

-

Market Access News, Publications, What's New

-

Posted by MORSE

MORSE Consulting Strengthens HTA Strategy and Payer Expertise

February 18, 2020

-

Market Access News, What's New

-

Posted by MORSE

Summary of the CADTH Drug Portfolio Information Session November 2019

December 2, 2019

-

Market Access News

-

Posted by MORSE

Update on the CanREValue Collaboration

November 12, 2019

-

Market Access News

-

Posted by MORSE

NEW Canadian Reimbursement Trends and Timelines Report – now available!

September 18, 2019

-

Market Access News, Publications, What's New

-

Posted by MORSE

Potential Impact of PMPRB Changes from a Regulatory, HTA and Payer Perspective

August 21, 2019

-

Market Access News, Publications

-

Posted by MORSE Team

CADTH Pharmaceutical Reviews Update – July 2019

August 16, 2019

-

Market Access News

-

Posted by MORSE Team

Spotlight on the Atlantic Provinces: pCPA Letter of Intent Conversion and Time-to-Listing Analysis

January 24, 2019

-

Market Access News, Publications

-

Posted by MORSE Team

Significant Developments in Canadian Drugs for Rare Disease Policy

November 14, 2018

-

Market Access News

-

Posted by MORSE Team

Patient Support Programs – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

November 1, 2018

-

Market Access News

-

Posted by MORSE Team

HTA Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 18, 2018

-

Market Access News

-

Posted by MORSE Team

MORSE Consulting Inc.

Toronto | Ottawa, Canada

+1-647-717-3179 (Toronto)

+1-613-864-8645 (Ottawa)

info@morseconsulting.ca

MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.

© 2020 MORSE Consulting Inc. All rights reserved. | Site by Directica Media

HTA - Info and details on - MORSE Consulting Inc.